Johnson & Johnson named the bioethicist Arthur L. Caplan to create a panel to decide on patients’ requests for lifesaving medicines before they are approved.
KATIE THOMAS, NY Times: Business
Wed, 05/06/2015 - 9:01pm
Johnson & Johnson named the bioethicist Arthur L. Caplan to create a panel to decide on patients’ requests for lifesaving medicines before they are approved.